Cargando…
The impact of COVID-19 on cardio-oncology care in Taiwan
COVID-19 has not only affected the respiratory but the cardiovascular system. Taiwan has encountered a less severe COVID-19 pandemic. We reported the current situation in Taiwan. In this study, we retrospectively analyzed the data from our cardio-oncology program since October of 2019 to April of 20...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Formosan Medical Association. Published by Elsevier Taiwan LLC.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8380481/ https://www.ncbi.nlm.nih.gov/pubmed/34454797 http://dx.doi.org/10.1016/j.jfma.2021.08.020 |
_version_ | 1783741205308243968 |
---|---|
author | Kang, Nai-Wen Feng, Yin-Hsun Chen, Zhih-Cherng Chang, Wei-Ting |
author_facet | Kang, Nai-Wen Feng, Yin-Hsun Chen, Zhih-Cherng Chang, Wei-Ting |
author_sort | Kang, Nai-Wen |
collection | PubMed |
description | COVID-19 has not only affected the respiratory but the cardiovascular system. Taiwan has encountered a less severe COVID-19 pandemic. We reported the current situation in Taiwan. In this study, we retrospectively analyzed the data from our cardio-oncology program since October of 2019 to April of 2020 (the initial months of COVID-19 pandemic). In our cardio-oncology program, newly diagnosed breast cancer patients preparing for epirubicin therapy were included. Echocardiography, 6-min walking distance and major adverse cardiovascular events (MACEs) were recorded. To evaluate whether the social atmosphere affects cardio-oncology care, we analyzed the objective (physical) and subjective (emotional) parameters before and after January 21, 2020, when the first case of COVID-19 was confirmed in Taiwan. There was no significant decrease in patients’ return ratio and LVEFs. However, there was a trend of subjective shortness of breath reported by the patients but no decline in 6 MWT. Notably, none of the enrolled patients reported MACEs during the COVID pandemic. We observed an impact of anxiety on patients receiving epirubicin but it did not influence their return ratio. |
format | Online Article Text |
id | pubmed-8380481 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Formosan Medical Association. Published by Elsevier Taiwan LLC. |
record_format | MEDLINE/PubMed |
spelling | pubmed-83804812021-08-23 The impact of COVID-19 on cardio-oncology care in Taiwan Kang, Nai-Wen Feng, Yin-Hsun Chen, Zhih-Cherng Chang, Wei-Ting J Formos Med Assoc Short Communication COVID-19 has not only affected the respiratory but the cardiovascular system. Taiwan has encountered a less severe COVID-19 pandemic. We reported the current situation in Taiwan. In this study, we retrospectively analyzed the data from our cardio-oncology program since October of 2019 to April of 2020 (the initial months of COVID-19 pandemic). In our cardio-oncology program, newly diagnosed breast cancer patients preparing for epirubicin therapy were included. Echocardiography, 6-min walking distance and major adverse cardiovascular events (MACEs) were recorded. To evaluate whether the social atmosphere affects cardio-oncology care, we analyzed the objective (physical) and subjective (emotional) parameters before and after January 21, 2020, when the first case of COVID-19 was confirmed in Taiwan. There was no significant decrease in patients’ return ratio and LVEFs. However, there was a trend of subjective shortness of breath reported by the patients but no decline in 6 MWT. Notably, none of the enrolled patients reported MACEs during the COVID pandemic. We observed an impact of anxiety on patients receiving epirubicin but it did not influence their return ratio. Formosan Medical Association. Published by Elsevier Taiwan LLC. 2022-04 2021-08-23 /pmc/articles/PMC8380481/ /pubmed/34454797 http://dx.doi.org/10.1016/j.jfma.2021.08.020 Text en © 2021 Formosan Medical Association. Published by Elsevier Taiwan LLC. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Short Communication Kang, Nai-Wen Feng, Yin-Hsun Chen, Zhih-Cherng Chang, Wei-Ting The impact of COVID-19 on cardio-oncology care in Taiwan |
title | The impact of COVID-19 on cardio-oncology care in Taiwan |
title_full | The impact of COVID-19 on cardio-oncology care in Taiwan |
title_fullStr | The impact of COVID-19 on cardio-oncology care in Taiwan |
title_full_unstemmed | The impact of COVID-19 on cardio-oncology care in Taiwan |
title_short | The impact of COVID-19 on cardio-oncology care in Taiwan |
title_sort | impact of covid-19 on cardio-oncology care in taiwan |
topic | Short Communication |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8380481/ https://www.ncbi.nlm.nih.gov/pubmed/34454797 http://dx.doi.org/10.1016/j.jfma.2021.08.020 |
work_keys_str_mv | AT kangnaiwen theimpactofcovid19oncardiooncologycareintaiwan AT fengyinhsun theimpactofcovid19oncardiooncologycareintaiwan AT chenzhihcherng theimpactofcovid19oncardiooncologycareintaiwan AT changweiting theimpactofcovid19oncardiooncologycareintaiwan AT kangnaiwen impactofcovid19oncardiooncologycareintaiwan AT fengyinhsun impactofcovid19oncardiooncologycareintaiwan AT chenzhihcherng impactofcovid19oncardiooncologycareintaiwan AT changweiting impactofcovid19oncardiooncologycareintaiwan |